Contralateral Prophylactic Mastectomy with Immediate Breast Reconstruction Increases Healthcare Utilization and Cost

[1]  H. Cody,et al.  Contralateral Prophylactic Mastectomy (CPM) Consensus Statement from the American Society of Breast Surgeons: Data on CPM Outcomes and Risks , 2016, Annals of Surgical Oncology.

[2]  H. Cody,et al.  Contralateral Prophylactic Mastectomy Consensus Statement from the American Society of Breast Surgeons: Additional Considerations and a Framework for Shared Decision Making , 2016, Annals of Surgical Oncology.

[3]  I. Jatoi,et al.  Trends in use of contralateral prophylactic mastectomy by racial/ethnic group and ER/PR status among patients with breast cancer: A SEER population-based study. , 2016, Cancer epidemiology.

[4]  A. Degnim,et al.  Use of immediate breast reconstruction and choice for contralateral prophylactic mastectomy. , 2016, Surgery.

[5]  C. Steiner,et al.  Trends in Bilateral and Unilateral Mastectomies in Hospital Inpatient and Ambulatory Settings, 2005–2013 , 2016 .

[6]  R. Young.  Value-Based Cancer Care. , 2015, The New England journal of medicine.

[7]  Amanda K Silva,et al.  The Effect of Contralateral Prophylactic Mastectomy on Perioperative Complications in Women Undergoing Immediate Breast Reconstruction: A NSQIP Analysis , 2015, Annals of Surgical Oncology.

[8]  L. Hartmann,et al.  Impact of Reconstruction and Reoperation on Long-Term Patient-Reported Satisfaction After Contralateral Prophylactic Mastectomy , 2015, Annals of Surgical Oncology.

[9]  Nilay D Shah,et al.  Optum Labs: building a novel node in the learning health care system. , 2014, Health affairs.

[10]  D. Winchester,et al.  Changing surgical trends in young patients with early stage breast cancer, 2003 to 2010: a report from the National Cancer Data Base. , 2014, Journal of the American College of Surgeons.

[11]  K. Frick,et al.  Cost-Effectiveness of Contralateral Prophylactic Mastectomy for Prevention of Contralateral Breast Cancer , 2014, Annals of Surgical Oncology.

[12]  D. Winchester,et al.  Operative Risks Associated with Contralateral Prophylactic Mastectomy: A Single Institution Experience , 2013, Annals of Surgical Oncology.

[13]  T. Cil,et al.  Increased Postoperative Complications in Bilateral Mastectomy Patients Compared to Unilateral Mastectomy: An Analysis of the NSQIP Database , 2013, Annals of Surgical Oncology.

[14]  E. Halpern,et al.  Cost‐effectiveness of alternating magnetic resonance imaging and digital mammography screening in BRCA1 and BRCA2 gene mutation carriers , 2013, Cancer.

[15]  J. Sacks,et al.  Reconstructive Outcomes in Patients Undergoing Contralateral Prophylactic Mastectomy , 2011, Plastic and reconstructive surgery.

[16]  A. Degnim,et al.  Cost-effectiveness of contralateral prophylactic mastectomy versus routine surveillance in patients with unilateral breast cancer. , 2011, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

[17]  M. Morrow,et al.  Clinical management factors contribute to the decision for contralateral prophylactic mastectomy. , 2011, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

[18]  A. Neugut,et al.  Comparative effectiveness of screening and prevention strategies among BRCA1/2-affected mutation carriers , 2011, Breast Cancer Research and Treatment.

[19]  L. Lostumbo,et al.  Prophylactic mastectomy for the prevention of breast cancer. , 2010, Cochrane Database of Systematic Reviews.

[20]  T. Tuttle,et al.  Increasing rates of contralateral prophylactic mastectomy among patients with ductal carcinoma in situ. , 2009, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

[21]  T. Tuttle,et al.  Increasing use of contralateral prophylactic mastectomy for breast cancer patients: a trend toward more aggressive surgical treatment. , 2007, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

[22]  A. Neugut,et al.  Cost-Effectiveness of Preventive Strategies for Women with a BRCA1 or a BRCA2 Mutation , 2006, Annals of Internal Medicine.

[23]  T. Sellers,et al.  Reoperations after prophylactic mastectomy with or without implant reconstruction , 2003, Cancer.

[24]  R. Deyo,et al.  Adapting a clinical comorbidity index for use with ICD-9-CM administrative databases. , 1992, Journal of clinical epidemiology.

[25]  A. Cohen.  What is value in health care? , 2011, The New England journal of medicine.

[26]  Injury rates by industry 1970, BLS Report 406, Department of Labor, Bureau of Labor Statistics. , 1972, IMS, Industrial medicine and surgery.